Education
About Us
Working with TipRanks
Follow Us
QNXT - ETF AI Analysis
Top Page
iShares Nasdaq-100 ex Top 30 ETF (QNXT)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several top holdings, such as Lam Research and Intel, have delivered strong year-to-date performance, supporting the ETF’s overall gains.
Sector Diversification
The ETF is spread across multiple sectors, including Technology, Consumer Cyclical, and Health Care, reducing reliance on any single industry.
Low Expense Ratio
The fund’s expense ratio is relatively low, making it cost-effective for investors compared to other ETFs.
Negative Factors
High Technology Exposure
With over 42% of the portfolio in Technology, the ETF is heavily reliant on the performance of this sector, increasing sensitivity to tech market volatility.
Limited Geographic Exposure
The ETF is overwhelmingly focused on U.S. companies, offering minimal exposure to international markets.
Underperforming Holdings
Some top holdings, such as Comcast and Automatic Data Processing, have lagged in year-to-date performance, potentially dragging down returns.
QNXT vs. SPDR S&P 500 ETF (SPY)
AUM16.73M
RegionNorth America
Expense Ratio0.20%
Beta1.08
IssueriShares
Inception DateOct 23, 2024
Dividend Yield0.64%
Asset ClassEquity
Index TrackedNasdaq-100 ex Top 30 Index - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,306
30 Day Avg. Volume1,457
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.00Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering70
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QNXT Summary
The iShares Nasdaq-100 ex Top 30 ETF (Ticker: QNXT) is a fund that lets investors own shares in large-cap companies from the Nasdaq-100 Index, but it excludes the top 30 biggest companies. This means it focuses on the next tier of growing businesses in sectors like technology, healthcare, and consumer goods. Some well-known companies in this ETF include Intel and Lam Research. People might invest in QNXT to diversify their portfolio and tap into the growth potential of innovative companies that aren’t yet market giants. However, since it’s heavily focused on tech and growth-oriented sectors, its value can rise and fall with market trends.
How much will it cost me?The iShares Nasdaq-100 ex Top 30 ETF (QNXT) has an expense ratio of 0.20%, meaning you’ll pay $2 per year for every $1,000 invested. This cost is lower than average for actively managed funds but slightly higher than many passively managed ETFs, as it focuses on a unique niche within the Nasdaq-100 Index.
What would affect this ETF?The QNXT ETF, with its focus on large-cap companies in technology, healthcare, and consumer sectors, could benefit from continued innovation and growth in these industries, especially as emerging leaders gain market share. However, it may face challenges from rising interest rates, which can impact growth-oriented stocks, and economic slowdowns that could affect consumer spending and corporate investments. Additionally, regulatory changes in the tech and healthcare sectors could create uncertainty for some of its top holdings.
QNXT Top 10 Holdings
The iShares Nasdaq-100 ex Top 30 ETF (QNXT) leans heavily on technology, with nearly half of its portfolio in the sector, including names like Lam Research and Intel. Lam Research is rising steadily, fueled by its focus on AI and advanced technologies, while Intel’s mixed performance reflects profitability challenges despite revenue growth. KLA is holding steady, benefiting from demand in advanced packaging, though export controls on China remain a headwind. On the downside, Analog Devices and Comcast are lagging, with weak momentum and bearish signals. With its U.S.-centric exposure, QNXT offers a fresh take on large-cap innovation but faces hurdles from valuation concerns and sector-specific risks.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lam Research | 4.54% | $744.06K | $205.06B | 106.09% | 77 Outperform | |
| Intel | 3.65% | $598.54K | $177.97B | 86.79% | 64 Neutral | |
| KLA | 3.58% | $587.18K | $160.74B | 85.81% | 77 Outperform | |
| Analog Devices | 3.08% | $505.76K | $136.32B | 30.45% | 78 Outperform | |
| CrowdStrike Holdings | 2.73% | $447.46K | $123.16B | 34.61% | 67 Neutral | |
| Vertex Pharmaceuticals | 2.67% | $437.38K | $115.43B | 0.45% | 78 Outperform | |
| Comcast | 2.58% | $423.57K | $108.33B | -19.92% | 72 Outperform | |
| Automatic Data Processing | 2.49% | $407.76K | $106.03B | -7.98% | 70 Outperform | |
| Constellation Energy Corporation | 2.46% | $404.05K | $114.18B | 51.03% | 72 Outperform | |
| Mercadolibre | 2.24% | $367.93K | $98.03B | 11.65% | 77 Outperform |
QNXT Technical Analysis
Neutral
―
Price Trends
27.64
Negative
27.15
Positive
25.93
Positive
Market Momentum
0.10
Positive
44.98
Neutral
2.93
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QNXT, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 27.51, equal to the 50-day MA of 27.64, and equal to the 200-day MA of 25.93, indicating a neutral trend. The MACD of 0.10 indicates Positive momentum. The RSI at 44.98 is Neutral, neither overbought nor oversold. The STOCH value of 2.93 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for QNXT.
QNXT Peer Comparison
Comparison Results
Performance Comparison
QNXT
iShares Nasdaq-100 ex Top 30 ETF
27.34
3.24
13.44%
ONEO
SPDR Russell 1000 Momentum Focus ETF
―
―
―
LRND
IQ U.S. Large Cap R&D Leaders ETF
―
―
―
LVDS
JPMorgan Fundamental Data Science Large Value ETF
―
―
―
UPSD
Aptus Large Cap Upside ETF
―
―
―
BCUS
Bancreek U.S. Large Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents